Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12102638 Use of vibegron to treat overactive bladder

Patent 12102638 was granted and assigned to Urovant Sciences on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Urovant Sciences
Urovant Sciences
0
Date Filed
June 6, 2018
0
Date of Patent
October 1, 2024
0
Patent Applicant
Urovant Sciences
Urovant Sciences
0
Patent Application Number
16620179
0
Patent Citations
‌
US Patent 8247415 Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
0
‌
US Patent 7342117 α-form or β-form crystal of acetanilide derivative
0
‌
US Patent 7396958 Sulphonamide derivatives, their preparation and their therapeutic application
0
‌
US Patent 7982049 α-form or β-form crystal of acetanilide derivative
0
‌
US Patent 10065922 Solabegron zwitterion and uses thereof
0
‌
US Patent 10087189 Process for making beta 3 agonists and intermediates
0
‌
US Patent 10287289 Process for preparing beta 3 agonists and intermediates
0
‌
US Patent 10350182 Pharmaceutical compositions and the treatment of overactive bladder
0
‌
US Patent 10435410 Process for making beta 3 agonists and intermediates
0
‌
US Patent 10577316 Process for making beta 3 agonists and intermediates
0
•••
Patent Inventor Names
Paul Mudd
0
Stephen C. Piscitelli
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12102638
0
Patent Primary Examiner
‌
Alicia L Otton
0
CPC Code
‌
A61P 13/10
0
‌
A61K 31/519
0
‌
A61K 9/0053
0
‌
A61K 9/2018
0
‌
A61K 9/2054
0
‌
A61K 9/2833
0

Find more entities like US Patent 12102638 Use of vibegron to treat overactive bladder

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo